X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-14 | AARD | Decheng Capital Global Life Sciences Fund Iv, L.P. | 10% | P - Purchase | $16.00 | +1,250,000 | 3,917,299 | +47% | +$20,000,000 | |||||
| D | 2025-02-14 | AARD | Lee Tien-Li | CEO, 10% | P - Purchase | $16.00 | +16,542 | 2,970,203 | +1% | +$264,672 | |||||
| D | 2025-02-14 | AARD | Sun Nelson | CFO | P - Purchase | $16.00 | +10,000 | 99,484 | +11% | +$160,000 | |||||
| D | 2025-02-14 | AARD | Cormorant Asset Management, LP | Former 10% Owner | P - Purchase | $16.00 | +187,500 | 987,689 | +23% | +$3,000,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |